RE:RE:Type C Meeting TimingsListen to the RBC Capital Markets Global Healthcare Conference Fireside Chat .... Matt Coffey stated that the FDA Type C meeting with a focus on ONCY's planned registration-enabling trial for pelareorep in breast cancer was scheduled for approximately 35 days after the date of request.